Fighting for Our Lives (link) With a platform already in place, Nanōmix had a significant head start. It developed a 10-minute blood test to detect the presence of antibodies in people who’ve recovered from COVID-19.
TechNation Radio: "A 15-Minute COVID-19 Detector?" (link) TechNation host Moira Gunn talks with Nanomix President and CEO David Ludvigson about the development of 15-minute point-of-care SARS-CoV-2 antigen and antibody tests that will run on the Nanomix eLab analyzer.
San Francisco Business Times: How California plans to break the logjam for COVID-19 tests. (link) Staff Reporter Ron Leuty writes about a California task force that is working to make adequate numbers of COVID-19 tests available, including serology-based tests. The story describes Nanomix's work to develop rapid, point-of-care COVID-19 tests, and quotes CEO David Ludvigson who says, "The serological testing is really going to be important … for getting the world back moving again."
Nanōmix at AACC 2013 in Houston (PDF) Abby Jones from Corgenix will be presenting at the July 31 Poster Session on a Corgenix and Nanomix Collaboration for the development of a handheld mulitplex POC diagnostic for Lassa fever, Dengue fever and Ebola Hemorrhagic Fever.